NCT06552299 Evaluating Length and Depth Estimation Accuracy of Laypersons and Health-Care Providers
| NCT ID | NCT06552299 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Cardiopulmonary Resuscitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-08-27 |
| Primary Completion | 2025-01-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-08-27 with a primary completion date of 2025-01-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the study is to measure accurateness of length and depth estimation of laypersons and health-care providers.
Eligibility Criteria
Inclusion criteria: * Laypersons: adult laypersons without cardiopulmonary resuscitation training within 2 years * Health-care providers: adult health-care providers (doctors, nurses and emergency medical technicians) Exclusion criteria: * Laypersons: laypersons with cardiopulmonary resuscitation training within 2 years. * Health-care providers: health-care providers who are inactive (not currently working at medical facilities)
Contact & Investigator
STEPHEN GW LEE, MD, MA
PRINCIPAL INVESTIGATOR
SMG-SNU Boramae Medical Center
Frequently Asked Questions
Who can join the NCT06552299 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiopulmonary Resuscitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06552299 currently recruiting?
Yes, NCT06552299 is actively recruiting participants. Contact the research team at LEESTEPHENGYUNGWON@GMAIL.COM for enrollment information.
Where is the NCT06552299 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06552299 clinical trial?
NCT06552299 is sponsored by Seoul National University Hospital. The principal investigator is STEPHEN GW LEE, MD, MA at SMG-SNU Boramae Medical Center. The trial plans to enroll 200 participants.